HistoSonics Inc. specializes in advanced medical technology designed for the non-invasive mechanical destruction of liver tumors through histotripsy. Their system offers a novel approach to partially or completely treat unresectable liver tumors, providing potential new options for patients. Committed to safety and efficacy, the device is restricted by US federal law to sale only by or on the order of a qualified physician, emphasizing responsible use. The system is intended for use exclusively by professionals trained by HistoSonics, who apply clinical judgment to optimize patient care. Although the FDA has not evaluated this device for specific cancer indications or outcomes, comprehensive training and detailed instructions accompany its deployment to ensure informed and cautious application.